2.89
price up icon17.48%   0.43
pre-market  시장 영업 전:  3.04   0.15   +5.19%
loading
전일 마감가:
$2.46
열려 있는:
$2.7
하루 거래량:
1.33M
Relative Volume:
7.92
시가총액:
$99.82M
수익:
-
순이익/손실:
$-28.30M
주가수익비율:
-2.3884
EPS:
-1.21
순현금흐름:
$-21.30M
1주 성능:
+20.92%
1개월 성능:
+27.31%
6개월 성능:
+30.77%
1년 성능:
-76.21%
1일 변동 폭
Value
$2.70
$3.41
1주일 범위
Value
$2.25
$3.41
52주 변동 폭
Value
$1.60
$12.36

Genelux Corp Stock (GNLX) Company Profile

Name
명칭
Genelux Corp
Name
전화
805-267-9889
Name
주소
2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Name
직원
25
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
GNLX's Discussions on Twitter

GNLX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
GNLX
Genelux Corp
2.89 99.82M 0 -28.30M -21.30M -1.21
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
427.89 110.19B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
687.80 75.58B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
647.39 38.71B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
264.99 34.18B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
117.25 28.11B 3.30B -501.07M 1.03B -2.1146

Genelux Corp Stock (GNLX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-29 개시 Guggenheim Buy
2024-08-28 개시 ROTH MKM Buy
2023-11-27 개시 H.C. Wainwright Buy
2023-09-12 개시 Maxim Group Buy
2023-02-15 개시 The Benchmark Company Speculative Buy

Genelux Corp 주식(GNLX)의 최신 뉴스

pulisher
Jan 12, 2025

Geode Capital Management LLC Has $749,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Jan 12, 2025
pulisher
Dec 31, 2024

Genelux director Tyree James L sells shares worth $8,511 - Investing.com India

Dec 31, 2024
pulisher
Dec 30, 2024

Genelux director Tyree James L sells shares worth $8,511 By Investing.com - Investing.com Nigeria

Dec 30, 2024
pulisher
Dec 23, 2024

XTX Topco Ltd Invests $59,000 in Genelux Co. (NASDAQ:GNLX) - Defense World

Dec 23, 2024
pulisher
Dec 19, 2024

Genelux VP sells shares worth $14,742 By Investing.com - Investing.com Australia

Dec 19, 2024
pulisher
Dec 18, 2024

Genelux CFO Zak Lourie sells $4,921 in stock By Investing.com - Investing.com Australia

Dec 18, 2024
pulisher
Dec 18, 2024

Genelux's head of regulatory sells $5,873 in stock By Investing.com - Investing.com Australia

Dec 18, 2024
pulisher
Dec 18, 2024

Genelux CFO Zak Lourie sells $4,921 in stock - Investing.com

Dec 18, 2024
pulisher
Dec 13, 2024

Genelux Corporation to Participate in a Fireside Chat with H.C. Wainwright - Yahoo Finance

Dec 13, 2024
pulisher
Nov 19, 2024

HC Wainwright Cuts Genelux (NASDAQ:GNLX) Price Target to $30.00 - Defense World

Nov 19, 2024
pulisher
Nov 15, 2024

Genelux shares target cut, maintains buy rating on 3Q earnings - Investing.com

Nov 15, 2024
pulisher
Nov 14, 2024

Genelux reports Q3 EPS (19c), consensus (19c) - TipRanks

Nov 14, 2024
pulisher
Nov 14, 2024

Genelux Reports $6.5M Q3 Loss, Advances Lung Cancer Trials with $35.1M Cash Runway - StockTitan

Nov 14, 2024
pulisher
Nov 08, 2024

Genelux Corp. Releases New Corporate Presentation - TipRanks

Nov 08, 2024
pulisher
Nov 06, 2024

Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Genelux CEO to Present at Guggenheim Healthcare Innovation Conference - StockTitan

Nov 06, 2024
pulisher
Oct 31, 2024

Individual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as well - Yahoo Finance

Oct 31, 2024
pulisher
Oct 31, 2024

Guggenheim Begins Coverage on Genelux (NASDAQ:GNLX) - Defense World

Oct 31, 2024
pulisher
Oct 29, 2024

Guggenheim sees upside in Genelux shares, targets $8 as pivotal cancer trial progresses - Investing.com India

Oct 29, 2024
pulisher
Oct 29, 2024

Brokerages Set Genelux Co. (NASDAQ:GNLX) PT at $22.33 - MarketBeat

Oct 29, 2024
pulisher
Oct 25, 2024

Highbridge Capital Management LLC Acquires Significant Stake in Genelux Corp - Yahoo Finance

Oct 25, 2024
pulisher
Oct 23, 2024

Genelux doses first subject in Phase II trial of NSCLC treatment - Yahoo Finance

Oct 23, 2024
pulisher
Oct 22, 2024

Genelux advances NSCLC treatment with Phase 2 Olvi-Vec trial - Investing.com

Oct 22, 2024
pulisher
Oct 22, 2024

Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer - Yahoo Finance

Oct 22, 2024
pulisher
Oct 17, 2024

Cubist Systematic Strategies LLC Takes $56,000 Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Oct 17, 2024
pulisher
Oct 14, 2024

Genelux Co. (NASDAQ:GNLX) Shares Sold by Renaissance Technologies LLC - Defense World

Oct 14, 2024
pulisher
Oct 09, 2024

Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit - Yahoo Finance

Oct 09, 2024
pulisher
Oct 04, 2024

Genelux announces executive departure By Investing.com - Investing.com Australia

Oct 04, 2024
pulisher
Oct 03, 2024

Genelux announces executive departure - Investing.com

Oct 03, 2024
pulisher
Oct 01, 2024

Point72 Asia Singapore Pte. Ltd. Acquires Shares of 20,162 Genelux Co. (NASDAQ:GNLX) - Defense World

Oct 01, 2024
pulisher
Sep 25, 2024

Affinity Asset Advisors LLC Acquires New Position in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 25, 2024
pulisher
Sep 19, 2024

Highbridge Capital Management LLC Invests $1.23 Million in Genelux Co. (NASDAQ:GNLX) - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Short Interest in Genelux Co. (NASDAQ:GNLX) Decreases By 7.3% - MarketBeat

Sep 18, 2024
pulisher
Sep 14, 2024

Genelux corp insider sells over $170k in company stock - Investing.com India

Sep 14, 2024
pulisher
Sep 12, 2024

Genelux director Tyree James L sells shares worth over $4,400 - Investing.com India

Sep 12, 2024
pulisher
Sep 11, 2024

Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells $63,134.10 in Stock - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

Genelux corp insider sells over $196k in company stock - Investing.com

Sep 11, 2024
pulisher
Sep 11, 2024

ROTH MKM analysts initates a Buy rating for Genelux Corp (GNLX) - Knox Daily

Sep 11, 2024
pulisher
Sep 07, 2024

Genelux Corp insider sells $89.6k in company stock By Investing.com - Investing.com Australia

Sep 07, 2024
pulisher
Sep 06, 2024

Genelux Corp insider sells $89.6k in company stock - Investing.com India

Sep 06, 2024
pulisher
Sep 06, 2024

Insider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 42,818 Shares of Stock - MarketBeat

Sep 06, 2024
pulisher
Sep 06, 2024

Genelux Corp [NASDAQ: GNLX] Sees Increase in Stock Value - Knox Daily

Sep 06, 2024
pulisher
Sep 06, 2024

Genelux Corp (GNLX) Stock: A Year of Decreases and Increases - The InvestChronicle

Sep 06, 2024
pulisher
Sep 03, 2024

Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference - Yahoo Finance

Sep 03, 2024
pulisher
Sep 02, 2024

Genelux Corp (GNLX) may enjoy gains as insiders got busy in the recent days - Knox Daily

Sep 02, 2024
pulisher
Sep 01, 2024

Aladar Szalay Sells 107,045 Shares of Genelux Co. (NASDAQ:GNLX) Stock - Defense World

Sep 01, 2024

Genelux Corp (GNLX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
자본화:     |  볼륨(24시간):